Publications by authors named "Yohei Urata"

Claim this Profile
A
A case of mixed neuroendocrine non-neuroendocrine neoplasm of the distal bile duct with biliary intraepithelial neoplasia.
Miyuki Kaino, Seiji Kaino, Wakana Goma, Eizaburo Hideura, Tomoki Hitosugi, Yohei Urata

Clin J Gastroenterol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment.
Issei Saeki, Takahiro Yamasaki, Satoyoshi Yamashita, Tadasuke Hanazono, Yohei Urata

Cancers (Basel)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.
Issei Saeki, Takahiro Yamasaki, Norikazu Tanabe, Takuya Iwamoto, Toshihiko Matsumoto, Yohei Urata

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and prognosis of non-B non-C hepatocellular carcinoma patients with modest alcohol consumption.
Yohei Urata, Takahiro Yamasaki, Issei Saeki, Shuji Iwai, Masaaki Kitahara

Hepatol Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of tyrosine with insulin resistance in hepatitis C virus-related chronic liver disease.
Takashi Oono, Takahiro Yamasaki, Junichi Zaitsu, Issei Saeki, Takuya Iwamoto, Yohei Urata

Hepatol Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells.
Shuji Terai, Taro Takami, Naoki Yamamoto, Koichi Fujisawa, Tsuyoshi Ishikawa, Yohei Urata

Tissue Eng Part B Rev· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic gemcitabine combined with hepatic arterial infusion chemotherapy with cisplatin, 5-fluorouracil, and isovorin for the treatment of advanced intrahepatic cholangiocarcinoma: a pilot study.
Miho Marumoto, Takahiro Yamasaki, Yoshio Marumoto, Issei Saeki, Yohei Harima, Yohei Urata

Hepatogastroenterology· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum transferrin as a predictor of prognosis for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma.
Junichi Zaitsu, Takahiro Yamasaki, Issei Saeki, Yohei Harima, Takuya Iwamoto, Yohei Urata

Hepatol Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma.
Takahiro Yamasaki, Issei Saeki, Yohei Harima, Junichi Zaitsu, Masaki Maeda, Yohei Urata

J Gastroenterol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.
Shuji Terai, Haruko Tanimoto, Masaki Maeda, Junichi Zaitsu, Takuro Hisanaga, Yohei Urata

J Gastroenterol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous high expression of XBP1 and GRP78 is important for the survival of bone marrow cells in CCl4-treated cirrhotic liver.
Yoshio Marumoto, Shuji Terai, Yohei Urata, Toshihiko Matsumoto, Yuko Mizunaga, Tomoaki Murata

Biochem Biophys Res Commun· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of supplementation with branched-chain amino acids in patients with liver cirrhosis.
Yohei Urata, Kosuke Okita, Keiko Korenaga, Koichi Uchida, Takahiro Yamasaki

Hepatol Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice.
Tsuyoshi Ishikawa, Shuji Terai, Yohei Urata, Yoshio Marumoto, Koji Aoyama, Tomoaki Murata

Cell Tissue Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.
Shuji Terai, Tsuyoshi Ishikawa, Kaoru Omori, Koji Aoyama, Yoshio Marumoto, Yohei Urata

Stem Cells· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of serum marker proteins in recipient mice with liver cirrhosis after bone marrow cell transplantation.
Yuichiro Yokoyama, Shuji Terai, Tsuyoshi Ishikawa, Koji Aoyama, Yohei Urata

Proteomics· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes.
Tsuyoshi Ishikawa, Shuji Terai, Yohei Urata, Yoshio Marumoto, Koji Aoyama, Tomoaki Murata

Cell Tissue Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis